News

Role of Mitochondria in Heart Disease Should Not Be Underestimated

  Researchers have reviewed the role of mitochondria in cardiac diseases, highlighting different aspects of these multifaceted organelles and pointing out key processes, that, if deregulated, can lead to heart disease. Heart muscle cells – or cardiomyocytes – rely heavily on mitochondria for their energy needs. Different mitochondrial processes that can be…

New Method Measures Mitochondrial Capacity to Produce Energy in Individual Muscles

A noninvasive method for analyzing the effectiveness of mitochondrial energy production in individual muscle groups shows promise to improve assessments in people with mitochondrial disease. Researchers hope the new method will complement current methods, based on magnetic resonance spectroscopy, to improve diagnostics, long-term monitoring, and evaluation of treatment response in…

Experimental MitoQ Treatment Fails Prevention of Age-Related Muscle Mass, Function Loss in Mice

Researchers used a long-term treatment approach of MitoQ (mitoquinone mesylate) in aging experimental mice, but the treatment had no beneficial effects on mitochondrial function or on muscle mass and function. The study, “Long-term administration of the mitochondria-targeted antioxidant mitoquinone mesylate fails to attenuate age-related oxidative damage or rescue the loss of…

Improved Mitochondrial Function May Positively Affect Spinal Cord Injuries

Researchers recently reviewed the importance of the mitochondria, the cell’s energy production factories, with special focus on spinal cord injury (SCI) and the development of comorbidities such as Type 2 diabetes and obesity. They found that improvement of mitochondrial function may decrease cell death and metabolic function in these patients. In…

Phase 2 Trial on Therapy for Hospitalized Patients with Congestive Heart Failure Begun

Stealth Bio, a company that develops drugs to treat mitochondrial dysfunction and genetic mitochondrial diseases, recently launched Phase 2 of the clinical trial IDDEA-HF assessing elamipretide in patients hospitalized with congestive heart failure. Heart failure affects about 21 million people in the U.S. and Europe with cases expected to rise as populations continue to age. Heart…

Scientists Develop New Peptides as Novel Therapies for Mitochondrial Diseases

A study led by researchers at Washington University School of Medicine and Albert Einstein College of Medicine found a new route to correct dysfunctional mitochondria. The scientists designed small compounds that could help treat Charcot-Marie-Tooth disease (CTMD) and other mitochondrial diseases. The study, “Correcting mitochondrial fusion by manipulating mitofusin conformations,” was recently published…

Rapamycin Use Increased Lifespan in Leigh Syndrome Animal Models

Both mouse and fruit fly animal models of Leigh syndrome suggest that blocking a specific pathway controlled by the protein TOR increases animals’ lifespan. The results suggest that a future therapeutic strategy for Leigh syndrome, and possibly other mitochondria diseases, may require TOR inhibition. The study, “Rapamycin enhances survival…